Heming Wu

Title: Innovations of Heming Wu in Adipose Tissue-Targeting Polypeptides

Introduction

Heming Wu is a notable inventor based in Nanjing, China. He has made significant contributions to the field of biomedical engineering, particularly in the development of targeted drug delivery systems for obesity treatment. His innovative approach combines polypeptides with nanotechnology to enhance drug efficacy.

Latest Patents

Heming Wu holds a patent for an "Adipose tissue-targeting polypeptide-verbascoside-nanogold particle derivative, preparation method and application thereof." This patent outlines a method for preparing a derivative that targets adipose tissue, which is crucial for delivering drugs effectively to treat obesity. The process involves activating a carboxyl group of a cysteine residue, esterifying it with verbascoside, and reacting it with PEG-modified nanogold particles. The resulting derivative demonstrates excellent biocompatibility and significantly improves the targeted anti-obesity activity of drugs.

Career Highlights

Heming Wu has worked at the Affiliated Stomatological Hospital of Nanjing Medical University and Nanjing Medical University. His experience in these institutions has allowed him to collaborate with leading researchers and contribute to advancements in medical science.

Collaborations

Heming Wu has collaborated with notable colleagues, including Yi Yuan and Yaqin Zhang. Their joint efforts have furthered research in the field of targeted therapies and drug delivery systems.

Conclusion

Heming Wu's innovative work in developing adipose tissue-targeting polypeptides represents a significant advancement in obesity treatment. His contributions to the field highlight the importance of combining biotechnology with nanotechnology for effective medical solutions.